[Urothelial carcinoma after treatment with cyclophosphamide. Review of the literature and presentation of our caseload]. / Carcinoma de urotelio tras tratamiento con ciclofosfamida. Revisión de la literatura y aportación de nuestra casuística.
Actas Urol Esp
; 17(2): 139-42, 1993 Feb.
Article
em Es
| MEDLINE
| ID: mdl-8480522
ABSTRACT
Cyclophosphamide has been used since 1958 in the treatment of various malignant tumours and certain systemic diseases, toxicity to the urothelium, frequently causing haemorrhagic cystitis and less often urothelial carcinomas, being one of its most notorious side effects--some 60 urothelial carcinoma cases have been published following therapy with cyclophosphamide since 1971. The present paper is a contribution of two new cases and its raises the need of paying special attention to urinary manifestations as well as narrowing the cooperation between the physicians which prescribe cyclophosphamide and the urologist, in order to make an appropriate follow-up and management of the patient.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Bexiga Urinária
/
Carcinoma de Células de Transição
/
Ciclofosfamida
Limite:
Humans
/
Male
/
Middle aged
Idioma:
Es
Revista:
Actas Urol Esp
Ano de publicação:
1993
Tipo de documento:
Article